Sharp Therapeutics Statistics

Total Valuation

TSXV:SHRX has a market cap or net worth of CAD 63.16 million. The enterprise value is 63.61 million.

Market Cap	63.16M
Enterprise Value	63.61M

Important Dates

The next estimated earnings date is Friday, May 1, 2026.

Earnings Date	May 1, 2026
Ex-Dividend Date	n/a

Share Statistics

TSXV:SHRX has 30.08 million shares outstanding. The number of shares has increased by 227.37% in one year.

Current Share Class	30.08M
Shares Outstanding	30.08M
Shares Change (YoY)	+227.37%
Shares Change (QoQ)	-7.26%
Owned by Insiders (%)	4.39%
Owned by Institutions (%)	0.70%
Float	16.43M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
PB Ratio	-260.84
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-7.51
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 1.06

Current Ratio	1.06
Quick Ratio	1.00
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-33.03

Financial Efficiency

Return on equity (ROE) is -512.77% and return on invested capital (ROIC) is -137.64%.

Return on Equity (ROE)	-512.77%
Return on Assets (ROA)	-105.91%
Return on Invested Capital (ROIC)	-137.64%
Return on Capital Employed (ROCE)	-552.75%
Weighted Average Cost of Capital (WACC)	-0.43%
Revenue Per Employee	n/a
Profits Per Employee	n/a
Employee Count	n/a
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +162.50% in the last 52 weeks. The beta is -0.91, so TSXV:SHRX's price volatility has been lower than the market average.

Beta (5Y)	-0.91
52-Week Price Change	+162.50%
50-Day Moving Average	2.86
200-Day Moving Average	n/a
Relative Strength Index (RSI)	39.11
Average Volume (20 Days)	3,792

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-7.56M
Pretax Income	-8.47M
Net Income	-8.47M
EBITDA	-7.54M
EBIT	-7.56M
Earnings Per Share (EPS)	-0.29

Full Income Statement

Balance Sheet

The company has 1.31 million in cash and 1.76 million in debt, giving a net cash position of -446,886 or -0.01 per share.

Cash & Cash Equivalents	1.31M
Total Debt	1.76M
Net Cash	-446,886
Net Cash Per Share	-0.01
Equity (Book Value)	-242,133
Book Value Per Share	-0.01
Working Capital	83,083

Full Balance Sheet

Cash Flow

Operating Cash Flow	-6.62M
Capital Expenditures	n/a
Depreciation & Amortization	18,931
Net Borrowing	-273,654
Free Cash Flow	n/a
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

TSXV:SHRX does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-227.37%
Shareholder Yield	-227.37%
Earnings Yield	-13.40%
FCF Yield	n/a

Stock Splits

The last stock split was on January 27, 2025. It was a reverse split with a ratio of 0.1.

Last Split Date	Jan 27, 2025
Split Type	Reverse
Split Ratio	0.1

Scores

Altman Z-Score	n/a
Piotroski F-Score	1